Gilead small molecule demonstrates strong capability for HIV prevention
According to Gilead, the study is the first Phase III…
According to Gilead, the study is the first Phase III HIV prevention trial to demonstrate a zero-infection rate.
List view / Grid view
According to Gilead, the study is the first Phase III…
According to Gilead, the study is the first Phase III HIV prevention trial to demonstrate a zero-infection rate.
Study is the first 'prevention of infection' trial conducted for…
Study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer...